PRC
ABBV icon

Platte River Capital’s AbbVie ABBV Stock Holding History

Platte River Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,700
Closed -$217K – 159
2015
Q1 		$217K Sell
3,700
-20,950
-85% -$1.27M 0.1% 146
2014
Q4 		$1.61M Sell
24,650
-19,870
-45% -$1.25M 0.6% 62
2014
Q3 		$2.57M Sell
44,520
-42,900
-49% -$2.38M 0.66% 53
2014
Q2 		$4.93M Sell
87,420
-25,900
-23% -$1.36M 0.75% 50
2014
Q1 		$5.83M Sell
113,320
-13,700
-11% -$692K 0.79% 44
2013
Q4 		$6.71M Buy
127,020
+30,600
+32% +$1.5M 0.86% 34
2013
Q3 		$4.31M Sell
96,420
-9,750
-9% -$432K 0.53% 71
2013
Q2 		$4.39M Buy
+106,170
New +$4.64M 0.51% 74

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Platte River Capital's ABBV Position: Q2 2015 in Review

Platte River Capital sold out of AbbVie (ABBV) in Q2 2015, closing a stake of 3,700 shares — an estimated $217K sold.

Platte River Capital first reported a position in ABBV in Q2 2013 and held it in 8 quarters. The position peaked at $6.71M in Q4 2013. 1,652 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

  • Platte River Capital reported no remaining AbbVie position as of Q2 2015 after selling out during the quarter.
  • Platte River Capital sold 3,700 AbbVie shares in Q2 2015, an estimated $217K.
  • Platte River Capital first reported a position in AbbVie in Q2 2013 and held it in 8 quarters.
  • Platte River Capital's AbbVie position peaked at $6.71M in Q4 2013.
  • 1,652 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on Platte River Capital's 13F filing for Q2 2015, filed 10 Aug 2015.